Skip to main content
SpringerLink
Log in

Koronare Herzkrankheit — akute Verlaufsformen

  • Chapter
Herz Kreislauf kompakt

  • 2559 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur zu Kapitel 8

  1. Allan JJ et al (1997) Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 30(4):1052–1056

    Article  PubMed  CAS  Google Scholar 

  2. Alpert JS et al (2000) Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36(3):959–969

    Article  PubMed  CAS  Google Scholar 

  3. Andersen HR, Falk E, Nielsen D (1987) Right ventricular infarction: frequency, size and topography in coronary heart disease: a prospective study comprising 107 consecutive autopsies from a coronary care unit. J Am Coll Cardiol 10(6):1223–1232

    Article  PubMed  CAS  Google Scholar 

  4. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction (1993) The GUSTO investigators. N Engl J Med 329(10):673–682

    Article  Google Scholar 

  5. Andersen HR et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349(8):733–742

    Article  PubMed  Google Scholar 

  6. Anderson JL, Karagounis LA, Califf RM (1996) Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol 78(1):1–8

    Article  PubMed  CAS  Google Scholar 

  7. Antman EM et al (1996) Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335(18):1342–1349

    Article  PubMed  CAS  Google Scholar 

  8. Antman EM et al (2000) The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. Jama 284(7):835–842

    Article  PubMed  CAS  Google Scholar 

  9. Antman EM et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110(5):588–636

    Article  PubMed  Google Scholar 

  10. Armstrong PW et al (1998) Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 98(18):1860–1868

    PubMed  CAS  Google Scholar 

  11. Becker RC et al (1996) A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 27(6):1321–1326

    Article  PubMed  CAS  Google Scholar 

  12. Berger PB et al (1997) Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation 96(1):122–127

    PubMed  CAS  Google Scholar 

  13. Boersma E et al (2000) Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 101(22):2557–2567

    PubMed  CAS  Google Scholar 

  14. Boersma E et al (2002) Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 359(9302):189–198

    Article  PubMed  CAS  Google Scholar 

  15. Braunwald E et al (1994) Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 90(1):613–622

    PubMed  CAS  Google Scholar 

  16. Braunwald E et al (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40(7):1366–1374

    Article  PubMed  Google Scholar 

  17. Buffon A et al (2002) Widespread coronary inflammation in unstable angina. N Engl J Med 347(1):5–12

    Article  PubMed  Google Scholar 

  18. Cannon CP et al (1997) The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 30(1):133–140

    Article  PubMed  CAS  Google Scholar 

  19. Cannon CP et al (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344(25):1879–1887

    Article  PubMed  CAS  Google Scholar 

  20. Carrier M et al (2000) Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 69(2):435–440

    Article  PubMed  CAS  Google Scholar 

  21. Crenshaw BS et al (2000) Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (-Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 101(1):27–32

    PubMed  CAS  Google Scholar 

  22. DeWood MA et al (1983) Coronary arteriographic findings in acute transmural myocardial infarction. Circulation 68(2 Pt 2):I39–49

    PubMed  CAS  Google Scholar 

  23. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction (1994) Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 89(4):1545–1556

    Google Scholar 

  24. Ellis SG et al (1994) Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 90(5):2280–2284

    PubMed  CAS  Google Scholar 

  25. Ellis SG et al (2000) Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 139(6):1046–1053

    Article  PubMed  CAS  Google Scholar 

  26. Every NR et al (1996) Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery. Myocardial Infarction Triage and Intervention Investigators. Circulation 94(9 Suppl):II81–86

    PubMed  CAS  Google Scholar 

  27. Falk E (1983) Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 50(2):127–134

    PubMed  CAS  Google Scholar 

  28. Fox KA et al (2002) Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 23(15):1177–1189

    Article  PubMed  CAS  Google Scholar 

  29. Freda BJ et al Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol, 2002. 40(12):p. 2065–2071

    Article  PubMed  CAS  Google Scholar 

  30. Gerhardt W et al (2000) Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 46(6 Pt 1):817–821

    PubMed  CAS  Google Scholar 

  31. Goldberg RJ et al (1999) Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340(15):1162–1168

    Article  PubMed  CAS  Google Scholar 

  32. Goldberg RJ et al (2001) Recent magnitude of and temporal trends (1994–1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. Am Heart J 141(1):65–72

    Article  PubMed  CAS  Google Scholar 

  33. Goldstein JA et al (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343(13):915–922

    Article  PubMed  CAS  Google Scholar 

  34. Goodman SG et al (2000) Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. J Am Coll Cardiol 36(5):1507–1513

    Article  PubMed  CAS  Google Scholar 

  35. Hamm CW, Braunwald E (2000) A classification of unstable angina revisited. Circulation 102(1):118–122

    PubMed  CAS  Google Scholar 

  36. Hamm CW, Giannitsis E, Katus HA (2002) Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 106(23):2871–2872

    Article  PubMed  Google Scholar 

  37. Hamm CW (2004) [Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations]. Z Kardiol 93(1):72–90

    Article  PubMed  CAS  Google Scholar 

  38. Hamm CW (2004) [Guidelines: Acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation]. Z Kardiol 93(4):324–341

    Article  PubMed  CAS  Google Scholar 

  39. Hasdai D et al (2002) A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 23(15):1190–1201

    Article  PubMed  CAS  Google Scholar 

  40. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study (1999) Fragmin and Fast Revascularisation during Instability in Coronary artery disease Investigators. Lancet 354(9180):708–715

    Article  Google Scholar 

  41. James SK et al (2003) Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 41(6):916–924

    Article  PubMed  CAS  Google Scholar 

  42. Kastrati A, Mehilli J, Schühlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann F-J, Bollwein H, Volmer C, Gawaz M., Berger PB, Schömig A (2004) For the intracoronary stenting and antithrombotic regimen-rapid early action for coronary treatment (ISAR-REACT) study investigators, a clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with Clopidogrel. N Engl J Med 350::232–238

    Article  PubMed  CAS  Google Scholar 

  43. Kaul P et al (2001) Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol 38(1):64–71

    Article  PubMed  CAS  Google Scholar 

  44. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351):13–20

    Article  PubMed  Google Scholar 

  45. Kerensky RA et al (2002) Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 39(9):1456–1463

    Article  PubMed  Google Scholar 

  46. Killip T, 3rd, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20(4):457–464

    Article  PubMed  Google Scholar 

  47. Kishon Y et al (1992) Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients. Mayo Clin Proc 67(11):1023–1030

    PubMed  CAS  Google Scholar 

  48. Kuulasmaa K et al (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355(9205):675–687

    Article  PubMed  CAS  Google Scholar 

  49. Lavie CJ, Gersh BJ (1990) Mechanical and electrical complications of acute myocardial infarction. Mayo Clin Proc 65(5):709–730

    PubMed  CAS  Google Scholar 

  50. Lemery R et al (1992) Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol 70(2):147–151

    Article  PubMed  CAS  Google Scholar 

  51. Liebson PR, Klein LW (1997) The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis 39(5):399–444

    Article  PubMed  CAS  Google Scholar 

  52. Lindahl B, Venge P, Wallentin L (1996) Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 93(9):1651–1657

    PubMed  CAS  Google Scholar 

  53. Lindahl B et al (2001) Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 38(4):979–986

    Article  PubMed  CAS  Google Scholar 

  54. Mark DB et al (1991) Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy. Results from the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry. Circulation 83(4):1186–1193

    PubMed  CAS  Google Scholar 

  55. Mehta SR et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358(9281):527–533

    Article  PubMed  CAS  Google Scholar 

  56. Morrow DA et al (2002) An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 23(3):223–229

    Article  PubMed  CAS  Google Scholar 

  57. Neumann FJ et al (2003) Evaluation of prolonged antithrombotic pretreatment (“cooling-off” strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. Jama. 290(12):1593–1599

    Article  PubMed  CAS  Google Scholar 

  58. Newby LK et al (2000) Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med 342(11):749–755

    Article  PubMed  CAS  Google Scholar 

  59. Nomenclature and criteria for diagnosis of ischemic heart disease (1979) Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59(3):607–609

    Google Scholar 

  60. Nordmann AJ et al (2004) Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Am J Med 116(4):253–262

    Article  PubMed  Google Scholar 

  61. Oler A et al (1996) Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. Jama 276(10):811–815

    Article  PubMed  CAS  Google Scholar 

  62. Raghu C, Peddeswara Rao P, Seshagiri Rao D (1999) Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy. Int J Cardiol 71(3):209–215

    Article  PubMed  CAS  Google Scholar 

  63. Roe MT et al (2000) Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation 102(10):1101–1106

    PubMed  CAS  Google Scholar 

  64. Sacks FM et al (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335(14):1001–1009

    Article  PubMed  CAS  Google Scholar 

  65. Santoro GM et al (2000) A randomized study of intravenous magnesium in acute myocardial infarction treated with direct coronary angioplasty. Am Heart J 140(6):891–897

    Article  PubMed  CAS  Google Scholar 

  66. Shaw LW (1981) Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after myocardial infarction. The National Exercise and Heart Disease Project. Am J Cardiol 48(1):39–46

    Article  PubMed  CAS  Google Scholar 

  67. Shivkumar K, Schultz L, Goldstein S, Gheorghiade M (1998) Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression. Am Heart J 135(2 Pt l):261–267

    Article  PubMed  CAS  Google Scholar 

  68. Steinhubl SR et al (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama 288(19):2411–2420

    Article  PubMed  CAS  Google Scholar 

  69. Stevenson WG et al (1989) The spectrum of death after myocardial infarction: a necropsy study. Am Heart J 118(6):1182–1188

    Article  PubMed  CAS  Google Scholar 

  70. Taylor RS et al (2004) Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116(10):682–692

    Article  PubMed  Google Scholar 

  71. Thieme T et al (1996) Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol 28(1):1–6

    Article  PubMed  CAS  Google Scholar 

  72. Topol EJ et al (1988) A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med 318(17):1083–1088

    Article  PubMed  CAS  Google Scholar 

  73. Topol EJ, Neumann EJ, Montalescot G (2003) A preferred reperfusion strategy for acute myocardial infarction. J Am Coll Cardiol 42(11):1886–1889

    Article  PubMed  Google Scholar 

  74. Tunstall-Pedoe H et al (1999) Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353(9164):1547–1557

    Article  PubMed  CAS  Google Scholar 

  75. Tunstall-Pedoe H et al (2000) Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 355(9205):688–700

    Article  PubMed  CAS  Google Scholar 

  76. van Miltenburg-van Zijl AJ et al (1995) Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol 25(6):1286–1292

    Article  PubMed  Google Scholar 

  77. Warkentin TE et al (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332(20): 1330–1335

    Article  PubMed  CAS  Google Scholar 

  78. Wong GC et al (2002) Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation 106(2):202–207

    Article  PubMed  CAS  Google Scholar 

  79. Yusuf S et al (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494–502

    Article  PubMed  CAS  Google Scholar 

  80. Zimmerman J et al (1999) Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 99(13):1671–1677

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kardiologische Praxis, i.d. Main-Taunus-Kliniken, Kronberger Straße 36, 65812, Bad Soden

    Prof. Dr. med. N. Reifart

Authors
  1. Prof. Dr. med. N. Reifart
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kardiologische Fachklinik, Herz- und Kreislaufzentrum, Rotenburg an der Fulda, Heinz-Meise-Str. 100, 36199, Rotenburg a.d.F.

    Christian Vallbracht

  2. Falltorweg 8, 63309, Dreieich

    Martin Kaltenbach

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Reifart, N. (2006). Koronare Herzkrankheit — akute Verlaufsformen. In: Vallbracht, C., Kaltenbach, M. (eds) Herz Kreislauf kompakt. Steinkopff. https://doi.org/10.1007/3-7985-1615-4_9

Download citation

  • DOI: https://doi.org/10.1007/3-7985-1615-4_9

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1495-9

  • Online ISBN: 978-3-7985-1615-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation